-
Notifications
You must be signed in to change notification settings - Fork 14
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
p.v constant asymptomatic infectivity #316
p.v constant asymptomatic infectivity #316
Conversation
There was a problem hiding this comment.
Choose a reason for hiding this comment
The reason will be displayed to describe this comment to others. Learn more.
Thanks Richard - one Q and a possible test simplification
/benchmark |
3386313
to
e1060c0
Compare
7236985
to
5cb5a1e
Compare
f48ac97
to
c3dc720
Compare
5cb5a1e
to
ac353fd
Compare
ac353fd
to
5cd9688
Compare
5cd9688
to
f5df32d
Compare
… infectivity is affected by age and immunity. We must therefore change this when asymptomatic infectivity is assigned (when an individual become asymptomatic). This occurs in initial assignments, when someone becomes infected to an asymptomatic status infection and when a clinical diseased individual progresses to asymptomatic. We can use the existing update_infection() function for vivax in human_infection and in disease progression. We can also now remove the gamma1 parameter from the vivax parameter list, used in the falciparum code. The P.v vignette has been extended to include modelled infectivity details.
f5df32d
to
97837f3
Compare
/benchmark |
There was a problem hiding this comment.
Choose a reason for hiding this comment
The reason will be displayed to describe this comment to others. Learn more.
LGTM
/benchmark |
This is how benchmark results would change (along with a 95% confidence interval in relative change) if 97837f3 is merged into dev:
Further explanation regarding interpretation and methodology can be found in the documentation. |
p.v has a constant asymptomatic infectivity, in contrast to p.f where infectivity is affected by age and immunity. We must therefore change this when asymptomatic infectivity is assigned (when an individual become asymptomatic). This occurs in initial assignments, when someone becomes infected to an asymptomatic status infection and when a clinical diseased individual recovers to asymptomatic. We can now use the existing update_infection() function for vivax in human_infection and in disease progression.
We now remove the gamma1 parameter from the vivax parameter list, used in the falciparum code.